Pla H, Fullana B, Esteve A, Fort-Culillas R, Ferrando-Díez A, Fernández-Ortega A, Pous A, Stradella A, Villanueva-Vázquez R, Cirauqui B, Falo C, Martínez-Pérez E, Molina G, Del Barco S, Eraso A, Margelí M, Viñas G, Gil-Gil M, Petriz L, Pernas S
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.
Llombart-Cussac A, Harper-Wynne C, Perelló A, Hennequin A, Fernández-Ortega A, Colleoni M, Marín S, Quiroga V, Medioni J, Iranzo V, Wheatley D, Del Barco Berrón S, Antón A, Dobi E, Ruiz-Borrego M, Alcalá-López D, Pérez-Escuredo J, Antonarelli G, Sampayo-Cordero M, Pérez-García JM, Cortés J
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.
Sabaté-Ortega, J, Ribera-Montserrat, A, del Barco, S, Roqué-Lloveras, A, Fort-Culillas, R, Carmona-García, MC, Liñan, R, Polonio-Alcalá, E, Carbó-Vilavedra, G, Ramos-Oliver, I, Bujons-Buscarons, E, Montañés-Ferrer, C, Viñas, G, Pla-Juher, H
Double trouble, managing bilateral inflammatory breast cancer: a case report
Ignatiadis, M, Saloustros, ES, Joaquim, A, Grillet, F, Marcou, Y, Pernas, S, Neven, P, Berron, SD, Ponce-Lorenzo, JJ, van Oordt, CWV, Kelly, CM, Fehr, MK, Razis, E, Foukakis, T, Lambertini, M, Bidard, FC, Poncet, C, Janni, W
EORTC-2129-BCG: Elacestrant for treating ER+/HER2-breast cancer patients with ctDNA relapse (TREAT ctDNA).
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)
Pla H, Felip E, Obadia V, Pernas S, Viñas G, Margelí M, Fort-Culillas R, Del Barco S, Sabaté N, Fort E, Lezcano C, Cirauqui B, Quiroga V, Stradella A, Gil Gil M, Esteve A, Recalde S
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort
Gately, L, Mesía, C, Sepúlveda, JM, del Barco, S, Pineda, E, Gironés, R, Fuster, J, Dumas, M, Gill, S, Navarro, LM, Herrero, A, Dowling, A, de las Peñas, R, Vaz, MA, Alonso, M, Lwin, Z, Harrup, R, Peralta, S, Long, A, Perez-Segura, P, Ahern, E, Garate, CO, Wong, M, Campbell, R, Cuff, K, Jennens, R, Gallego, O, Underhill, C, Martinez-Garcia, M, Covela, M, Cooper, A, Brown, S, Rosenthal, M, Torres, J, Collins, IM, Gibbs, P, Balana, C
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
Petrova D, Redondo-Sánchez D, Rodríguez-Barranco M, Marcos-Gragera R, Guevara M, Carulla M, López de Munain A, Vizcaíno A, Del Barco S, González-Flores E, Pollán M, Sánchez MJ
Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain.
Mazariegos, M, Girones, R, del Barco, S, Garcia, A, Velilla, G, Hernandez, A, Alonso, M, Ferreira, L, Luque, N, Fernández,, Quintanar, T, Peralta, S, Ceballos,, Iza, E, Sanchez, M, Martín, EP, Casado, EA, Mazarico, J, Duran, G, Alvarez, P, Ayala, P, Gallego, O, Sarabia, R, de las Penas, R, Nuñez,, Morilla,, Cunquero, A, Cheverria, N, Moya,, Vaz, M, Luque, R, Esteve, A, Pineda, E
P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY
